Taha Rbab, Mowallad Abdulfattah, Mufti Areej, Althaqafi Abdulhakeem, Jiman-Fatani Asif A, El-Hossary Dalia, Ossenkopp John, AlhajHussein Baraa, Kaaki Mai, Jawi Noha, Hassanien Ashraf, Alsaedi Asim
Transplant Infectious Disease, King Faisal Specialist Hospital and Research Center, Jeddah, SAU.
Pathology and Laboratory Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Cureus. 2023 Feb 16;15(2):e35050. doi: 10.7759/cureus.35050. eCollection 2023 Feb.
The aim of the study is to estimate the prevalence rate of carbapenem-resistant Enterobacteriaceae (CRE) and to determine the types of carbapenemase genes present in patients admitted to King Abdulaziz Medical City (KAMC-J) and King Abdulaziz University Hospital (KAUH), both in Jeddah, Saudi Arabia.
A total of 180 isolates were analyzed which were included on the basis of retrospective chart review of patients from KAMC-J and KAUH between 1 April 2017 to 30 March 2019. The prevalence of carbapenemase genes was evaluated by Xpert® Carba-R (Cepheid, Sunnyvale, CA, USA). We assessed the CRE prevalence and described their susceptibility to antimicrobial agents based on antibiogram reports. Results: showed a higher frequency of OXA-48 (79%) than NDM (11.7%) genes (p=0.007). The CRE prevalence in KAUH was 8% in 2017 and increased to 13% in 2018. In KAMC-J, the prevalence was 57% in 2018 and 61% in 2019. was found to be the most frequently isolated causative organism followed by The OXA-48 (76.1%) gene was predominant among overall isolates followed by NDM (13.9%); both genes coexisted in 6.1% of the isolates.
During the study period, the prevalence of CRE considerably rose in the two tertiary care institutions from western Saudi Arabia. In the CRE isolates, OXA-48 was discovered to be the most common gene. We recommend an antimicrobial resistance surveillance system to detect the emergence of resistant genes through use of new rapid diagnostic tests and monitor antimicrobial use in order to improve clinical outcomes of CRE infections given the severity of infection associated with the CRE isolates as well as the limited treatment options available.
本研究旨在估计耐碳青霉烯类肠杆菌科细菌(CRE)的流行率,并确定沙特阿拉伯吉达的阿卜杜勒阿齐兹国王医疗城(KAMC-J)和阿卜杜勒阿齐兹国王大学医院(KAUH)收治患者中存在的碳青霉烯酶基因类型。
通过对2017年4月1日至2019年3月31日期间KAMC-J和KAUH患者的回顾性病历审查,共分析了180株分离株。采用Xpert® Carba-R(美国加利福尼亚州森尼韦尔市的赛沛公司)评估碳青霉烯酶基因的流行情况。我们根据抗菌谱报告评估了CRE的流行率,并描述了它们对抗菌药物的敏感性。结果:显示OXA-48基因(79%)的频率高于NDM基因(11.7%)(p = 0.007)。KAUH中CRE的流行率在2017年为8%,2018年增至13%。在KAMC-J中,2018年的流行率为57%,2019年为61%。发现 是最常分离出的致病菌,其次是 OXA-48基因(76.1%)在所有分离株中占主导地位,其次是NDM基因(13.9%);6.1%的分离株中这两种基因共存。
在研究期间,沙特阿拉伯西部的两家三级医疗机构中CRE的流行率显著上升。在CRE分离株中,发现OXA-48是最常见的基因。鉴于与CRE分离株相关感染的严重性以及可用治疗选择有限,我们建议建立一个抗菌药物耐药监测系统,通过使用新的快速诊断测试来检测耐药基因的出现,并监测抗菌药物的使用情况,以改善CRE感染的临床结局。